Yahoo Web Search

Search results

  1. A serotonin–norepinephrine–dopamine reuptake inhibitor ( SNDRI ), also known as a triple reuptake inhibitor ( TRI ), is a type of drug that acts as a combined reuptake inhibitor of the monoamine neurotransmitters serotonin, norepinephrine, and dopamine. It does this by concomitantly inhibiting the serotonin transporter (SERT ...

  2. Serotonin–norepinephrine reuptake inhibitors ( SNRIs) are a class of antidepressant medications used to treat major depressive disorder (MDD), anxiety disorders, social phobia, chronic neuropathic pain, fibromyalgia syndrome (FMS), and menopausal symptoms. Off-label uses include treatments for attention-deficit hyperactivity disorder (ADHD ...

  3. en.wikipedia.org › wiki › IndatralineIndatraline - Wikipedia

    Indatraline. Indatraline hydrochloride ( Lu 19-005) is an antidepressive agent and non-selective monoamine transporter inhibitor that blocks the reuptake of dopamine, norepinephrine, and serotonin with similar efficacy to cocaine. [1] This compound may be used to treat cocaine addictions as its effects have a slower onset and a longer duration ...

  4. Serotonin reuptake inhibitor. A serotonin reuptake inhibitor ( SRI) is a type of drug which acts as a reuptake inhibitor of the neurotransmitter serotonin (5-hydroxytryptamine, or 5-HT) by blocking the action of the serotonin transporter (SERT). This in turn leads to increased extracellular concentrations of serotonin and, therefore, an ...

  5. en.wikipedia.org › wiki › LurasidoneLurasidone - Wikipedia

    Lurasidone. Lurasidone, sold under the brand name Latuda among others, is an antipsychotic medication used to treat schizophrenia and bipolar disorder. [2] It is taken by mouth . Common side effects include sleepiness, movement disorders, nausea, and diarrhea. [2]

  6. Distribution of VMAT2 in the human brain. The solute carrier family 18 member 2 ( SLC18A2) also known as vesicular monoamine transporter 2 ( VMAT2) is a protein that in humans is encoded by the SLC18A2 gene. [5] SLC18A2 is an integral membrane protein that transports monoamines —particularly neurotransmitters such as dopamine, norepinephrine ...

  7. A norepinephrine–dopamine reuptake inhibitor ( NDRI) is a drug used for the treatment of clinical depression, attention deficit hyperactivity disorder (ADHD), narcolepsy, and the management of Parkinson's disease. The drug acts as a reuptake inhibitor for the neurotransmitters norepinephrine and dopamine by blocking the action of the ...

  1. People also search for